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Abstract
Objective: The purpose of this study was to investigate the properties of the slow component of the delayed rectifier potassium current
(I ) in myocytes isolated from undiseased human left ventricles. Methods: The whole-cell configuration of the patch-clamp techniqueKs
was applied in 58 left ventricular myocytes from 15 hearts at 378C. Nisoldipine (1 mM) was used to block inward calcium current (I )Ca
and E-4031 (1–5 mM) was applied to inhibit the rapid component of the delayed rectifier potassium current (I ). Results: In 31Kr
myocytes, an E-4031 insensitive, but L-735,821 and chromanol 293B sensitive, tail current was identified which was attributed to the slow
component of I (I ). Activation of I was slow (t59036101 ms at 50 mV, n514), but deactivation of the current was relatively rapidK Ks Ks
(t5122.4611.7 ms at 240 mV, n519). The activation of I was voltage independent but its deactivation showed clear voltageKs
dependence. The deactivation was faster at negative voltages (about 100 ms at 250 mV) and slower at depolarized potentials (about 300
1
ms at 0 mV). In six cells, the reversal potential was 281.662.8 mV on an average which is close to the K equilibrium potential
1
suggesting K as the main charge carrier. Conclusion: In undiseased human ventricular myocytes, I exhibits slow activation and fastKs
deactivation kinetics. Therefore, in humans I differs from that reported in guinea pig, and it best resembles I described in dog andKs Ks
rabbit ventricular myocytes. Ó 2001 Elsevier Science B.V. All rights reserved.
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1. Introduction lated to humans. In spite of the well known difficulties in
obtaining human cardiac tissue for research purposes, there
The delayed rectifier potassium current (I ) is an have been several reports of I in human ventricularK K
important repolarizing current in the ventricle [1,2] that muscle. The I current was first described in man byKr
has been identified in various mammalian cardiac prepara- Veldkamp et al. [10] and by Li et al. [11] and it was further
tions [3–6]. In most species, I can be separated into rapid characterized by Iost et al. [12].K
(I ) and slow (I ) components that differ from one other The available data regarding I in human ventricularKr Ks Ks
in terms of their sensitivity to drugs, rectification charac- muscle are less certain than the available information on
teristics and kinetic properties [7–9]. Since the properties I as was thoroughly discussed in a recent editorial byKr
and relative magnitude of I and I show species and Veldkamp [13]. In right ventricular myocytes obtainedKr Ks
tissue dependent variation the question arises as to how the from explanted hearts, Li et al. [11] described an E-4031
findings obtained in experimental animals may be extrapo- insensitive and indapamide-sensitive current, which was
attributed to I . These measurements were, however,Ks
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performed in the presence of CdCl and BaCl making the into isolation solution supplemented with taurine (50 mM)2 2
interpretation of the results difficult. A previous report and CaCl (1.25 mM) for 15 min. The tissue chunks were2
from our laboratory noted that it was not possible to then gently agitated in a small beaker to obtain single cells.
identify I current in myocytes obtained from undiseased During the entire isolation procedure, the solutions wereKs
human left ventricle [12]. Although this latter study oxygenated (100% O ) and temperature was maintained at2
verified the presence of properties of I , it raised further 378C. The cells were allowed to settle to the bottom of theKr
questions about the existence of I in undiseased human beaker for 10 min, and then half of the supernatant wasKs
ventricular muscle [12]. replaced by new solution. These procedures were repeated
However, in recent experiments using different ex- three times. The cells in KB solution were stored at 48C,
perimental conditions (changing the content of pipette and and the cells stored in isolation solution (1.25 mM CaCl )2
extracellular solutions) we were able to record an E-4031- were maintained on 12–148C. The characteristics of IKs
insensitive, L-735,821- and chromanol 293B-sensitive current recorded from cells stored in KB solution did not
current in undiseased human ventricular myocytes. In the differ from those stored in isolation solution. At least 1 h
present study we describe the properties of this current, was allowed before the start of the experiments.
which we attribute to I .Ks
2.3. Solutions used for cell isolation:
2. Methods The composition of the solutions was as follows (in
mM): (a) cardioplegic solution: NaCl 110, KCl 16, MgCl2
212.1. Patients 16, CaCl 1.2, NaHCO 10; (b) isolation solution (Ca -2 3
free): NaCl 135, KCl 4.7, KH PO 1.2, MgSO 1.2,2 4 4
Cells were prepared from 15 undiseased donor hearts. HEPES 10, Na pyruvate 5, taurine 20, NaHCO 4.4,3
The hearts were obtained from general organ donor glucose 10 (pH 7.2 adjusted with NaOH); (c) KB solution:
patients (male57, female58; mean age544.364.3 years) KOH 90, L-glutamic acid 70, taurine 15, KCl 30, KH PO2 4
undergoing pulmonary and aortic valve transplantation 10, MgCl 0.5, HEPES 10, glucose 11, EGTA 0.5 (pH 7.32
surgery. Before explantation of the hearts, the patients did adjusted with KOH);
not receive any medication except for dobutamine,
furosemide and plasma expanders. The experimental proto- 2.4. Experimental techniques and solutions
col complied with the Declaration of World Medical
Association proclaimed in Helsinki and was approved by One drop of cell suspension was placed in a transparent
¨the Ethical Review Board of the Albert Szent-Gyorgyi recording chamber mounted on the stage of an inverted
Medical University (No. 51-57/1997 OEj). microscope (TMS Nikon Co, Tokyo, Japan) and the
individual myocytes were allowed to settle to the bottom
2.2. Cell isolation of the recording chamber for at least 5 min before
superfusion. Only rod-shaped cells, which showed clear
Ventricular myocytes were isolated from the human striations, were used. Although the yield varied greatly
hearts by an enzymatic dissociation procedure as described between isolations (from 5 to 70%), the ease with which
previously [12]. After explantation and removal of the seals were formed, the stability of the seals and the quality
valves, hearts were transported to the laboratory in cold of the measurements did not correlate with yield. Cell
(48C) cardioplegic solution. A portion of the left ventricu- capacitance (182615 pF, n519) was measured by apply-
lar wall was excised together with its arterial branch and ing 10 mV hyperpolarizing pulse from 210 mV. The
was mounted on a modified 60-cm high Langendorff holding potential was 290 mV. The capacity was measured
perfusion apparatus, where it was perfused through a by integration of the capacitive transient divided by the
branch of the left anterior descending coronary artery with amplitude of the voltage step (10 mV). HEPES-buffered
solutions in the following sequence: isolation solution Tyrode’s solution was used as normal superfusate. This
supplemented with 1 mM CaCl (10 min), isolation solution contained (mM): NaCl 144, NaH PO 0.33, KCl2 2 4
solution (10 min), isolation solution to which collagenase 4.0, CaCl 1.8, MgCl 0.53, glucose 5.5, and HEPES 5.02 2
(type I, 0.66 mg/ml, Sigma Chemical, St. Louis, MO, at pH of 7.4. Superfusion was maintained by gravity flow.
USA), elastase (type III, 0.045 mg/ml, Sigma) and bovine E-4031 (obtained as a gift from the Institute for Drug
serum albumin (fraction V, fatty acid free, 2 mg/ml, Research, Budapest, Hungary) was prepared freshly daily
Sigma) had been added (15 min). After the first step of as a 5-mM aqueous stock solution. Final bath concen-
enzymatic digestion, the solution was supplemented with trations of 1–5 mM E-4031 were chosen for experiments
protease (type XIV, 0.12 mg/ml, Sigma) for a further on the basis of studies showing that these concentrations
30–45 min. Portions of the left ventricular wall that were completely blocked I in guinea pig myocytes [7].Kr
clearly digested by the enzymes were cut into small pieces Chromanol 293 B (obtained as a gift from the Hoechst AG,
¨and were placed either into Kraft–Bruhe (KB) solution, or Frankfurt, Germany) was also prepared freshly daily in
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50% ethanol as a 5-mM stock solution. L-735,821 (ob-
tained as a gift from Merck-Sharpe & Dohme, NY, USA)
was prepared in 100% DMSO as a 1-mM stock solution
and was used at 100 nM in order to completely block IKs
as reported in dog [14]. Micropipettes were fabricated from
borosilicate glass capillaries (Clark, Reading, UK) using a
microprocessor controlled horizontal puller (Sutter Instru-
ments Co., Novato CA, USA) and had a resistance of
1.5–2.5 MOhm when filled with a solution containing (in
mM) KOH 100, KCl 20, K HPO 10, MgCl 5, K EGTA2 4 2 2
5, HEPES 10, Na ATP 5, KADP 0.5, Na pyruvate 5,2
glutamate 5, creatine 5, glucose 5. The pH of the solution
was adjusted to 7.2 with aspartic acid. The external
solution contained 1 mM nisoldipine (kind gift form Bayer
Hungary Ltd, Budapest) in order to completely block the
21inward Ca current (I ). To increase the amplitude of ICa Ks
most of the experiments were carried out in the presence of
1 mM forskolin. The inward sodium current (I ) wasNa
inactivated by applying a holding potential of 240 mV,
which largely inactivated the transient outward current
(I ) as well. The membrane currents were recorded withto
Axopatch-1D and Axopatch-200B patch-clamp amplifiers
(Axon Instruments, Foster City CA, USA) using the
whole-cell configuration of the patch-clamp technique.
After establishing high (1–10 GOhm) resistance seals by
gentle suction, the cell membrane beneath the tip of the
Fig. 1. Two components of the delayed rectifier potassium current inelectrode was disrupted by further suction or by applying
human ventricular myocytes. Representative current traces were recorded1.5 V electrical pulses for 1–5 ms. The series resistance
under control conditions (panel A), after application of 5 mM E-4031
was typically 4–8 MOhm before compensation (usually (panel B) and in the presence of 30 mM chromanol 293B and 5 mM
50–80% depending on the voltage protocols). Those E-4031 (panel C). The current was activated by depolarizing voltage
pulses to 50 mV with gradually increasing duration (from 10 to 5000 ms)experiments in which the series resistance was high, or
at pulse frequency of 0.05 Hz. The holding potential was 240 mV. Thesubstantially increased during the measurements, were
dotted line shows zero current level.discarded from the analysis. The membrane currents were
digitized using a 333-kHz analog-to-digital converter
(Digidata 1200, Axon Instruments, Foster City CA, USA) ms). In this particular experiment the pulse frequency was
under software control (pClamp 6.0 and 7.0, Axon Instru- 0.05 Hz. This was necessary because the deactivation of
ments). The results were analyzed using software programs I in human myocyte is very slow [12]. However, in theKr
purchased from Axon (pClamp 6.0 and 7.0, Axon Instru- rest of the study where I was abolished by E-4031, weKr
ments) and were low-pass filtered at 1 kHz. The experi- applied a pulse frequency of 0.1 Hz which allowed for the
ments were carried out at 378C. Numerical data are E-4031 insensitive tail current to be fully deactivated. The
expressed as mean6S.E.M. current was activated with a double exponential time
course (t 522.4 ms, t 52388 ms) suggesting that itfast slow
represented both I and I currents. Complete block ofKr Ks
3. Results I by 5 mM E-4031 markedly reduced the amplitude ofKr
the tail currents and changed its activation to a single
Results were obtained from 31 cells from 15 hearts exponential (t51763 ms) with a slow time course (Fig.
(average 2.1 cells /heart, range 1–4). We specifically chose 1B). Additional superfusion of the cell with 30 mM
to use only cells with high-quality seals and low, stable chromanol 293B, a blocker of I , entirely abolished thisKs
series resistance (R ), opting for a smaller number of residual tail current suggesting that this current indeeds
excellent recordings from each preparation rather than represented I (Fig. 1C). All of the other experiments onKs
more recordings of variable quality. In additional 27 cells I , therefore, were performed in the presence of 1 or 5Ks
we could either not observe I or the I amplitudes were mM E-4031 to completely block I , thereby facilitatingKs Ks Kr
so small that it was difficult to distinguish the current from the separation of I from I .Ks Kr
the noise. Since I is relatively small, and other currents (tran-Ks
1 21Fig. 1A shows tail currents elicited by test pulses to 50 sient outward, non-specific cation, chloride and Na /Ca
mV with gradually increasing duration (from 10 to 5000 exchanger currents) could be also activated during de-
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polarizing pulses and during the time course of experi- inset in Fig. 2A indicates that the I tail current deacti-Ks
ments, the tail current after the end of the test pulse was vated rapidly (t5122.4611.7 ms, from 50 mV, n519) and
measured to assess I . was completely eliminated by L-735,821, another moreKs
An instantaneous, background-like, outward current was specific blocker of I (see Fig. 2B). Fig. 2C indicatesKs
often developed in long lasting (45–90 min) measurements average data obtained in 12–14 cells showing the I tailKs
(see Figs. 1 and 2). This may represent a current activated current normalized to the cell capacitance in respect to
because of the dialysis between the pipette and the gradually increasing voltages. Currents were studied at a
intracellular milieu. holding potential (HP) of 240 mV. The cells were depolar-
Fig. 2A and B show representative current traces in the ized with 5000 ms long test pulses between 210 and 150
presence of 1 mM E-4031 under control conditions and mV and then clamped back to 240 mV. Tail current
after application of 100 nM L-735,821, respectively. The amplitude was measured as the difference between the
peak and the steady state current level at the end of the
pulse after returning back to 240 mV HP.
Fig. 3 shows the activation kinetics of I tail current.Ks
To determine the activation kinetics of I we used theKs
envelope of tails test protocol. From holding potential of
240 mV test pulses to 50 mV were applied with increasing
duration ranging from 100 to 5000 ms and the amplitude
of the tail currents was measured. Fig. 3 contains the result
Fig. 2. Representative current traces under control conditions (panel A)
and after application of 100 nM L-735,821 (panel B). The current was Fig. 3. The activation kinetics of human I tail current. Original currentKs
activated by 5000 ms long depolarizing voltage pulses from holding traces (top) and the normalized I tail current amplitude as a function ofKs
potential of 240 mV to various test potentials ranging from 210 to 50 test pulse duration (bottom) are shown. The curve was fitted by a single
mV in 10-mV increments (see inset in panel C). The pulse frequency was exponential function in order to show the calculation of the activation
0.1 Hz. The insets in panel A and B indicate the tail currents of the time constant. The activation kinetics of the current was studied by using
original traces. Panel C indicates the cell size normalized current–voltage test pulses with gradually increasing duration at 50 mV (see inset). The
relationship for I tail current expressed in pA/pF (n512–14). In all, 5 amplitude of I tail current was normalized to the maximum amplitudeKs Ks
mM E-4031 was present throughout the measurements. value recorded from the particular cell.
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of a representative experiment, indicating that activation of
the tail current was rather slow (9036101 ms at 50 mV,
n514). In some cells, the voltage dependence of activation
of I was also studied. The activation kinetics of the IKs Ks
tail current measured at 240 mV was apparently not
voltage dependent in the test voltage range of 10–60 mV
(Fig. 4A and B).
The voltage dependence of the deactivation kinetics of
I current was determined by the following protocol: IKs Ks
current was activated by 5-s long test pulse to 50 mV from
a holding potential of 240 mV. Then the cells were
clamped back to different voltages ranging from 250 to 0
mV. Fig. 4C indicates that the deactivation of I tailKs
current was clearly voltage dependent, i.e. being faster at
Fig. 5. The reversal potential of human I was measured by clampingnegative voltages (about 100 ms at 250 mV) and slower at Ks
the cells back to voltages between 290 and 230 mV after a 5000-ms longdepolarized potentials (about 300 ms at 0 mV).
depolarizing pulse to 50 mV from a holding potential of 240 mV (topThe reversal potential of I was measured by clampingKs trace left). The tail current in these measurements was determined as
the cells back to voltages between 2100 and 0 mV after a L-735,821 sensitive current (subtracting the current traces before and after
5000-ms long depolarizing pulse to 50 mV from a holding the application of 100 nM L-735,821) (bottom trace left). Linear
regression was applied concerning the data point negative to 240 mV.potential of 240 mV. The results of a representative
The reversal potential was calculated as the intersection of the fitted andexperiment are shown in Fig. 5. The tail current in these
the zero current lines (right).
measurements was determined as L-735,821 sensitive
Fig. 4. The voltage dependence of the activation and deactivation kinetics of human I . Original current traces illustrate the activation kinetics of humanKs
I at 10 mV (top) and 50 mV (bottom) test potentials (panel A). Activation kinetics as a function of the test potential (panel B) were measured by envelopeKs
of tails protocol (see inset). I current was activated by test pulses with duration from 100 to 5000 ms to various test potentials ranging from 10 to 60 mV,Ks
then the cells were clamped back to 240 mV. The amplitude of tail current as a function of the duration of the depolarizing test pulse was well fitted by a
single exponential function. The voltage dependence of the deactivation kinetics (panel C) was determined by using the voltage protocol indicating the
inset in panel C. I current was activated by 5000-ms long test pulse to 50 mV from holding potential of 240 mV. Then the cells were clamped back toKs
different potentials ranging from 250 to 0 mV and the deactivation time course of the tail current was fitted by a single exponential function.
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current (subtracting the current traces before and after I were completely blocked by 100 nM L-735,821 and 1Kr
application of 100 nM L-735,821). In six cells, the reversal mM E-4031 this current could not be due to the activation
potential was 281.662.8 mV on an average which is close of I .K
1 1to the K equilibrium potential suggesting K as the main
charge carrier.
Li et al. [11] reported a relatively large (about 200 pA)
4. DiscussionI tail current in myocytes obtained from the rightKs
ventricle in failing human hearts. In this latter study the
21 21 The main finding of the present study is that I exists inextracellular solution contained Cd and Ba to block Ks
undiseased human ventricular myocytes and, as in the dogI and I . These divalent ions, however, markedly alterCa K1
21 ventricle, exhibits slow activation and relatively rapidthe kinetics of I [12,15] and in particular Ba blocks IK K1
deactivation kinetics.in a voltage-dependent manner [16]. Therefore, in some
Earlier reports regarding the existence of I in humancells we also measured ‘I ’ in the presence of 0.5 mM KsKs
ventricular myocytes were controversial. In some studiesBaCl . As Fig. 6 shows, in the presence of the selective2
using diseased human ventricles no evidence was found forblocker of I (1 mM E-4031) and I (100 nM L-Kr Ks
I [10,17–19]. In our previous study we could identify I735,821), as expected, no tail current was recorded at 240 Ks Kr
but not I in undiseased human ventricular cells [12]. InmV after a step potential to 130 mV for various durations. Ks
the present study, we made use of a different pipetteCells were then exposed to 0.5 mM BaCl that elicited a2
solution to that used earlier [12], and it is not yet clearslowly developing tail current that resembled I , as it wasKs
which component of this solution is important for record-also found in two other cells. However, since both I andKs
ing I . It is also worth noting that the amplitude of the IKs Ks
tail current reported here is relatively small even in the
continuous presence of 1 mM forskolin. In addition, in 27
out of 58 cells I was either absent or was too small to beKs
distinguished from the noise. In an earlier report it was
suggested that I might be particularly sensitive to theKs
isolation technique and as such it was difficult to measure
it in human preparations [11].
One may speculate that this new pipette solution con-
1tained more free K than that used in our previous
22
experiments, and also contained HPO and ADP, which4
could enhance intracellular ATP synthesis. In addition, the
osmolarity of the new pipette solution was higher than that
used previously. This may explain the development of an
instantaneous outward current during the time course of
our experiments due to the activation of the swelling
induced chloride channels. In this study however no
attempt was made to clarify the nature of this current.
As mentioned above, in a fairly large number of cells in
this study and in the cells in our previous study [12] no
discernible I was recorded. It can not be ruled out eitherKs
that, in addition to the unavoidable slight variation in the
cell isolation technique, and the change in pipette solution,
the cells might have originated from different layers of the
ventricular wall, thereby reflecting regional heterogeneity
of the cells rather than merely a technical reason.
As already mentioned, in an earlier study in human
ventricular myocytes [11] a relatively large E-4031 in-
sensitive and indapamide sensitive tail current was ob-
21 21
served in the presence of Cd and Ba . This is the only
study so far in which I was reported in human ventricu-Ks
21 21Fig. 6. Ba induces a slowly activating outward tail current in a human lar cells. With Ba in the extracellular solution, however,
ventricular myocyte after complete block of both I and I . AfterKr Ks we could record an I like tail current in the presence ofKs
superfusion of the myocyte with 1 mM E-4031 and 100 nM L-735,821, I and I blockers. Hirano et al. [16] showed that theKs Krno tail current can be noticed (top), but following application of 0.5 mM 21Ba induced I block disappeared at positive stepBaCl a slowly developing tail current appears, which can not be K12
attributed to I (bottom). potentials, and slowly developed again after returning toKs
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negative voltages and may have appeared as a tail current. potential compared to the duration and the voltage range of
We therefore speculate that this tail current could be the the plateau phase of the action potential. Also, selective
21
result of voltage-dependent interactions of Ba with I blockers of I did not lengthen substantially the normalK1 Ks
channels. In the study of Li et al. [11], high concentration action potential in the dog papillary muscle, unless other
of indapamide (1 mM) was used to block I and separate repolarizing currents were affected [14]. Further studies areKs
it from I . However, indapamide at high concentrations now needed to elucidate the role of I in the repolariza-Kr Ks
blocks both I and I currents [20] and as such it could tion in the normal human ventricle.Ks K1
depress both the I tail current and the I current evokedKs K1
by BaCl , thereby making interpretation of this study of2
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